CHU

Yvoir

0 studies enrolling now · 1 studies all time

What they study most

HRAS Mutant Tumor, Other Squamous Cell Carcinoma (SCC) With HRAS Mutant Tumor, Squamous Cell Carcinoma Head and Neck Cancer (HNSCC), Thyroid Cancer

Studies at this site

• Phase II Study of Tipifarnib in Squamous Head and Neck Cancer With HRAS Mutations — Completed